Additional evidence of the abuse potential of quetiapine.
about
Concerns about quetiapineUsing molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine.Acute dyskinesia, myoclonus, and akathisa in an adolescent male abusing quetiapine via nasal insufflation: a case study.Effects of quetiapine treatment on cocaine self-administration and behavioral indices of sleep in adult rhesus monkeys.Evaluation of the Reinforcing Effect of Quetiapine, Alone and in Combination with Cocaine, in Rhesus Monkeys.Biological perspectives incarcerated care and quetiapine abuse.Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics.Non-medical use of olanzapine by people on methadone treatment.Quetiapine for the treatment of alcoholism: scientific rationale and review of the literature.The effect of quetiapine (Seroquel™) on conditioned place preference and elevated plus maze tests in rats when administered alone and in combination with (+)-amphetamine.Non-medical use of psychotropic prescription drugs among adolescents in substance use treatment.Is seroquel developing an illicit reputation for misuse/abuse?Olanzapine as the ideal "trip terminator"? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms.Abuse of combinations of gabapentin and quetiapine.Dependence on quetiapine in combination with zolpidem and clonazepam in bipolar depression.Olanzapine abuse.Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.
P2860
Q26773288-E7AEF7F7-6B46-42C3-BF80-7FAFC3A854FFQ33436079-E16CE4C0-2883-4CE5-8F6F-F1484F932D82Q34478205-0E28FD9A-F181-4903-AEFE-83900BADF505Q34979796-CBE417A5-E3CD-45EB-A79F-745E9EF9C0E7Q36503063-2B1848B3-4CBC-43B4-BAEE-15849313B85BQ37199284-ADDAFD88-6DAD-4187-8305-FBEC410B2D28Q37638936-9BAD220C-C96E-4E13-92B7-28ED8358FC35Q37704418-FA9087FE-0A00-4FF6-A9EB-66EEA353C679Q37795940-B822E937-09BA-4A81-80B5-22B3F8C22F66Q39197723-226175CF-CA1E-4E95-9A73-AD358AB26DE1Q39214571-055A8F2E-6A5C-48CF-A93B-7EB29FAD21FFQ39872698-A4C1465B-83DC-4363-AEE8-23024053C364Q40689652-074F391C-99A0-40E2-864C-B27EC20EBAE4Q43137791-11851FF6-C78D-434C-B44A-6BB011167B32Q45946171-7A752EF2-E8B1-4B60-845E-70CF782652E2Q48199978-C2DE3B3B-14D2-4DE3-904B-552445AE0DD1Q52318376-61E7AEC4-5871-4603-B2BB-BCB417FEE033
P2860
Additional evidence of the abuse potential of quetiapine.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Additional evidence of the abuse potential of quetiapine.
@ast
Additional evidence of the abuse potential of quetiapine.
@en
Additional evidence of the abuse potential of quetiapine.
@nl
type
label
Additional evidence of the abuse potential of quetiapine.
@ast
Additional evidence of the abuse potential of quetiapine.
@en
Additional evidence of the abuse potential of quetiapine.
@nl
prefLabel
Additional evidence of the abuse potential of quetiapine.
@ast
Additional evidence of the abuse potential of quetiapine.
@en
Additional evidence of the abuse potential of quetiapine.
@nl
P1476
Additional evidence of the abuse potential of quetiapine.
@en
P2093
James C Brister
Roy R Reeves
P304
P356
10.1097/SMJ.0B013E3180F62D53
P407
P577
2007-08-01T00:00:00Z